Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Publication Category: Medications

Will medications that mimic gut hormones or target their receptors eventually replace bariatric surgery?

A. Kokkinos; D. Tsilingiris; C. W. le Roux; F. Rubino; C. S. Mantzoros Will medications that mimic gut hormones or target their receptors eventually replace bariatric surgery? Metabolism

Double-blinded, randomized, and controlled study on the effects of canagliflozin after bariatric surgery: A pilot study

S. R. Kashyap; K. Kheniser; A. Aminian; P. Schauer; C. Le Roux; B. Burguera Double-blinded, randomized, and controlled study on the effects of canagliflozin after bariatric surgery: A pilot study Obes Sci Pract
Insulin Resistance & Diabetes

Link Between Increased Satiety Gut Hormones and Reduced Food Reward After Gastric Bypass Surgery for Obesity

A. P. Goldstone; A. D. Miras; S. Scholtz; S. Jackson; K. J. Neff; L. Pénicaud; J. Geoghegan; N. Chhina; G. Durighel; J. D. Bell; S. Meillon; C. W. le Roux Link Between Increased Satiety Gut Hormones and Reduced Food Reward After Gastric Bypass Surgery for Obesity J Clin Endocrinol Metab
Appetite & Satiety

A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus

M. A. Glaysher; A. Mohanaruban; C. G. Prechtl; A. P. Goldstone; A. D. Miras; J. Lord; N. Chhina; E. Falaschetti; N. A. Johnson; W. Al-Najim; C. Smith; J. V. Li; M. Patel; A. R. Ahmed; M. Moore; N. Poulter; S. Bloom; A. Darzi; C. Le Roux; J. P. Byrne; J. P A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus BMJ Open
Insulin Resistance & Diabetes

Physiological adaptations following Roux-en-Y gastric bypass and the identification of targets for bariatric mimetic pharmacotherapy

N. G. Docherty; C. W. Le Roux Physiological adaptations following Roux-en-Y gastric bypass and the identification of targets for bariatric mimetic pharmacotherapy Current Opinion in Pharmacology

Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial

R. V. Cohen; T. B. Z. Petry; A. D. Miras; C. M. Aboud; B. Johnson; T. M. Dos Santos; C. W. le Roux Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial Diabetes Care
Chronic Kidney Disease

Effect of bariatric surgery combined with medical therapy versus intensive medical therapy or calorie restriction and weight loss on glycemic control in Zucker diabetic fatty rats

K. Abegg; C. Corteville; N. G. Docherty; C. Boza; T. A. Lutz; R. Muñoz; C. W. le Roux Effect of bariatric surgery combined with medical therapy versus intensive medical therapy or calorie restriction and weight loss on glycemic control in Zucker diabetic fatty rats Am J Physiol Regul Integr Comp Physiol

Transversus Abdominis Plane Block in Laparoscopic Bariatric Surgery—a Systematic Review and Meta-Analysis of Randomized Controlled Trials

M. A. Aamir; S. M. Sahebally; H. Heneghan Transversus Abdominis Plane Block in Laparoscopic Bariatric Surgery—a Systematic Review and Meta-Analysis of Randomized Controlled Trials Obesity Surgery

I10W]tigerinin-1R enhances both insulin sensitivity and pancreatic beta cell function and decreases adiposity and plasma triglycerides in high-fat mice

D. K. Srinivasan; O. O. Ojo; B. O. Owolabi; J. M. Conlon; P. R. Flatt; Y. H. Abdel-Wahab I10W]tigerinin-1R enhances both insulin sensitivity and pancreatic beta cell function and decreases adiposity and plasma triglycerides in high-fat mice Acta Diabetol
Insulin Resistance & Diabetes

Multi-functional roles of chitosan as a potential protective agent against obesity

A. M. Walsh; T. Sweeney; B. Bahar; J. V. O'Doherty Multi-functional roles of chitosan as a potential protective agent against obesity PLoS One

Older posts

Newer posts

← Previous Page1 … Page24 Page25 Page26 Page27 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2026 ASOI